Jinyao Pharmaceutical (600488.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 45.699 million yuan, a year-on-year decrease of 33.92%.

Zhitong Finance APP News, Jinyao Pharmaceutical (600488.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 1.864 billion yuan, a year-on-year decrease of 16.37%; net profit attributable to the parent company was 45.699 million yuan, a year-on-year decrease of 33.92%; net profit after deducting non-recurring gains and losses was 45.7881 million yuan, a year-on-year decrease of 66.26%; basic earnings per share were 0.042 yuan.